Mayo joint venture looks for new uses for drug molecules

  A new venture between the Mayo Clinic and a Boston-area artificial intelligence firm will work with drug companies to discover whether molecules researched for treatment of one disease can effectively treat other conditions. The month-old research company is called Qrativ and will target conditions for which current treatments are lacking. Mayo’s partner in the joint venture is Cambridge-based Nference.


Link to Full Article: Mayo joint venture looks for new uses for drug molecules

Pin It on Pinterest

Share This